Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 11 Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Surveys and Questionnaires 53 Blood Specimen Collection 53 Specimen Handling 28 Radiotherapy 18 Observation 18 Interviews as Topic 13 Magnetic Resonance Spectroscopy 12 Surgical Procedures, Operative 10 Drug Therapy 10 Data Collection 10 Biopsy 10 Tomography, X-Ray Computed 9 darolutamide 8 Watchful Waiting 7 Standard of Care 7 ribociclib 6 palbociclib 6 Restraint, Physical 6 Patient Reported Outcome Measures 6 Magnetic Resonance Imaging 6 Immune Checkpoint Inhibitors 6 trastuzumab deruxtecan 5 Positron-Emission Tomography 5 Mass Screening 5 Genetic Testing 5 Esophagectomy 5 Breath Tests 5 Bevacizumab 5 enzalutamide 4 apalutamide 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Platinum Compounds × 90 days × Clear all

NCT05363319 2026-05-13

CEMI-LUNG

Regeneron Pharmaceuticals

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡